Sonendo, Inc. (SONX)
USD 2.19
(6.31%)
USD 2.19
(6.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -60.91 Million USD | -6.78% |
| 2022 | -57.05 Million USD | -17.63% |
| 2021 | -48.49 Million USD | -3.93% |
| 2020 | -46.66 Million USD | 5.34% |
| 2019 | -49.29 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.76 Million USD | 37.84% |
| 2024 Q2 | -7.36 Million USD | -8.92% |
| 2023 Q1 | -15.92 Million USD | -46.77% |
| 2023 FY | -60.91 Million USD | -6.78% |
| 2023 Q4 | -10.87 Million USD | 35.94% |
| 2023 Q2 | -17.69 Million USD | -11.06% |
| 2023 Q3 | -16.98 Million USD | 4.01% |
| 2022 Q4 | -10.85 Million USD | 25.65% |
| 2022 Q3 | -14.59 Million USD | 8.7% |
| 2022 Q2 | -15.98 Million USD | 3.04% |
| 2022 Q1 | -16.48 Million USD | -20.25% |
| 2022 FY | -57.05 Million USD | -17.63% |
| 2021 Q1 | -10.9 Million USD | 12.94% |
| 2021 FY | -48.49 Million USD | -3.93% |
| 2021 Q4 | -13.71 Million USD | -7.68% |
| 2021 Q3 | -12.73 Million USD | -14.21% |
| 2021 Q2 | -11.14 Million USD | -2.23% |
| 2020 Q2 | -11.77 Million USD | 0.0% |
| 2020 Q1 | -11.77 Million USD | 0.0% |
| 2020 FY | -46.66 Million USD | 5.34% |
| 2020 Q4 | -12.52 Million USD | -18.26% |
| 2020 Q3 | -10.59 Million USD | 10.02% |
| 2019 FY | -49.29 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 101.064% |
| Allurion Technologies Inc. | -82.3 Million USD | 25.983% |
| Artivion, Inc. | -30.69 Million USD | -98.498% |
| Avanos Medical, Inc. | -61.8 Million USD | 1.426% |
| Butterfly Network, Inc. | -133.69 Million USD | 54.436% |
| Butterfly Network, Inc. | -133.69 Million USD | 54.436% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 90.441% |
| Boston Scientific Corporation | 1.59 Billion USD | 103.824% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -315.262% |
| CONMED Corporation | 64.45 Million USD | 194.508% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 104.344% |
| Paragon 28, Inc. | -47.84 Million USD | -27.336% |
| Glaukos Corporation | -134.66 Million USD | 54.761% |
| Globus Medical, Inc. | 122.87 Million USD | 149.579% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -187.992% |
| Integer Holdings Corporation | 90.65 Million USD | 167.202% |
| Medtronic plc | 3.67 Billion USD | 101.657% |
| Nevro Corp. | -92.21 Million USD | 33.937% |
| Owlet, Inc. | -32.9 Million USD | -85.159% |
| Penumbra, Inc. | 90.95 Million USD | 166.978% |
| Vicarious Surgical Inc. | -71.07 Million USD | 14.284% |
| Smith & Nephew plc | 263 Million USD | 123.163% |
| STERIS plc | 378.23 Million USD | 116.106% |
| Stryker Corporation | 3.16 Billion USD | 101.925% |
| Vapotherm, Inc. | -58.19 Million USD | -4.684% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 105.949% |